Loss-of-function mutations in FancJ genes are found in FA patients as well as in breast cancer patients suggesting that FancJ is a bona fide tumor suppressor (Cantor and Guillemette, 2011; Suhasini and Brosh, 2013). Here, BRIP1 is linked to neoplasm.